253 related articles for article (PubMed ID: 31411525)
1. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
[TBL] [Abstract][Full Text] [Related]
2. Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice.
Mojiri A; Walther BK; Jiang C; Matrone G; Holgate R; Xu Q; Morales E; Wang G; Gu J; Wang R; Cooke JP
Eur Heart J; 2021 Nov; 42(42):4352-4369. PubMed ID: 34389865
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS.
Gete YG; Koblan LW; Mao X; Trappio M; Mahadik B; Fisher JP; Liu DR; Cao K
Aging Cell; 2021 Jul; 20(7):e13388. PubMed ID: 34086398
[TBL] [Abstract][Full Text] [Related]
4. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
5. Transient introduction of human telomerase mRNA improves hallmarks of progeria cells.
Li Y; Zhou G; Bruno IG; Zhang N; Sho S; Tedone E; Lai TP; Cooke JP; Shay JW
Aging Cell; 2019 Aug; 18(4):e12979. PubMed ID: 31152494
[TBL] [Abstract][Full Text] [Related]
6. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
Atchison L; Zhang H; Cao K; Truskey GA
Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
[TBL] [Abstract][Full Text] [Related]
7. Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome.
Mao X; Xiong ZM; Xue H; Brown MA; Gete YG; Yu R; Sun L; Cao K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628310
[TBL] [Abstract][Full Text] [Related]
8. Vascular senescence in progeria: role of endothelial dysfunction.
Xu Q; Mojiri A; Boulahouache L; Morales E; Walther BK; Cooke JP
Eur Heart J Open; 2022 Jul; 2(4):oeac047. PubMed ID: 36117952
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
[TBL] [Abstract][Full Text] [Related]
10. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
[TBL] [Abstract][Full Text] [Related]
11. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
[TBL] [Abstract][Full Text] [Related]
12. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
13. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
[TBL] [Abstract][Full Text] [Related]
14. An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria.
Lo CY; Tjong YW; Ho JC; Siu CW; Cheung SY; Tang NL; Yu S; Tse HF; Yao X
PLoS One; 2014; 9(1):e87273. PubMed ID: 24475260
[TBL] [Abstract][Full Text] [Related]
15. Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome.
Abutaleb NO; Atchison L; Choi L; Bedapudi A; Shores K; Gete Y; Cao K; Truskey GA
Sci Rep; 2023 Mar; 13(1):5032. PubMed ID: 36977745
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
[TBL] [Abstract][Full Text] [Related]
17. Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c.1824 C > T.
Perales S; Sigamani V; Rajasingh S; Czirok A; Rajasingh J
Cell Tissue Res; 2023 Oct; 394(1):189-207. PubMed ID: 37572165
[TBL] [Abstract][Full Text] [Related]
18. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
19. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
20. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
